37375759|t|Spasmolytic and Uroprotective Effects of Apigenin by Downregulation of TGF-beta and iNOS Pathways and Upregulation of Antioxidant Mechanisms: In Vitro and In Silico Analysis.
37375759|a|Apigenin is a phytochemical obtained from Chamomilla recutita. Its role in interstitial cystitis is not yet known. The present study is aimed at understanding the uroprotective and spasmolytic effects of apigenin in cyclophosphamide-induced interstitial cystitis. The uroprotective role of apigenin was analyzed by qRT-PCR, macroscopic analysis, Evans blue dye leakage, histological evaluation, and molecular docking. The spasmolytic response was measured by adding cumulative concentrations of apigenin to isolated bladder tissue pre-contracted with KCl (80 mM) and carbachol (10-9-10-4) on non-incubated and pre-incubated tissues with atropine, 4DAMP, methoctramine, glibenclamide, barium chloride, nifedipine, indomethacin, and propranolol. Apigenin inhibited pro-inflammatory cytokines (IL-6, TNF-alpha and TGF 1-beta) and oxidant enzymes (iNOS) while increasing antioxidant enzymes (SOD, CAT, and GSH) in CYP-treated groups compared to the control. Apigenin restored normal tissue of the bladder by decreasing pain, edema, and hemorrhage. Molecular docking further confirmed the antioxidant and anti-inflammatory properties of apigenin. Apigenin produced relaxation against carbachol-mediated contractions, probably via blockade of M3 receptors, KATP channels, L-type calcium channels, and prostaglandin inhibition. While the blockade of M2 receptors, KIR channels, and beta-adrenergic receptors did not contribute to an apigenin-induced spasmolytic effect, apigenin presented as a possible spasmolytic and uroprotective agent with anti-inflammatory, antioxidant effects by attenuating TGF-beta/iNOS-related tissue damage and bladder muscle overactivity. Thus, it is a potential agent likely to be used in treatment of interstitial cystitis.
37375759	0	11	Spasmolytic	Disease	
37375759	41	49	Apigenin	Chemical	MESH:D047310
37375759	71	79	TGF-beta	Gene	7040
37375759	175	183	Apigenin	Chemical	MESH:D047310
37375759	250	271	interstitial cystitis	Disease	MESH:D018856
37375759	356	367	spasmolytic	Disease	
37375759	379	387	apigenin	Chemical	MESH:D047310
37375759	391	407	cyclophosphamide	Chemical	MESH:D003520
37375759	416	437	interstitial cystitis	Disease	MESH:D018856
37375759	465	473	apigenin	Chemical	MESH:D047310
37375759	521	535	Evans blue dye	Chemical	-
37375759	597	608	spasmolytic	Disease	
37375759	670	678	apigenin	Chemical	MESH:D047310
37375759	726	729	KCl	Chemical	MESH:D011189
37375759	742	751	carbachol	Chemical	MESH:D002217
37375759	812	820	atropine	Chemical	MESH:D001285
37375759	822	827	4DAMP	Chemical	MESH:C042375
37375759	829	842	methoctramine	Chemical	MESH:C054938
37375759	844	857	glibenclamide	Chemical	MESH:D005905
37375759	859	874	barium chloride	Chemical	MESH:C024986
37375759	876	886	nifedipine	Chemical	MESH:D009543
37375759	888	900	indomethacin	Chemical	MESH:D007213
37375759	906	917	propranolol	Chemical	MESH:D011433
37375759	919	927	Apigenin	Chemical	MESH:D047310
37375759	942	954	inflammatory	Disease	MESH:D007249
37375759	966	970	IL-6	Gene	3569
37375759	972	981	TNF-alpha	Gene	7124
37375759	1063	1066	SOD	Gene	6647
37375759	1068	1071	CAT	Gene	847
37375759	1129	1137	Apigenin	Chemical	MESH:D047310
37375759	1190	1194	pain	Disease	MESH:D010146
37375759	1196	1201	edema	Disease	MESH:D004487
37375759	1207	1217	hemorrhage	Disease	MESH:D006470
37375759	1280	1292	inflammatory	Disease	MESH:D007249
37375759	1307	1315	apigenin	Chemical	MESH:D047310
37375759	1317	1325	Apigenin	Chemical	MESH:D047310
37375759	1354	1363	carbachol	Chemical	MESH:D002217
37375759	1470	1483	prostaglandin	Chemical	MESH:D011453
37375759	1601	1609	apigenin	Chemical	MESH:D047310
37375759	1618	1629	spasmolytic	Disease	
37375759	1638	1646	apigenin	Chemical	MESH:D047310
37375759	1671	1682	spasmolytic	Disease	
37375759	1717	1729	inflammatory	Disease	MESH:D007249
37375759	1766	1774	TGF-beta	Gene	7040
37375759	1788	1801	tissue damage	Disease	MESH:D017695
37375759	1806	1833	bladder muscle overactivity	Disease	MESH:D053201
37375759	1899	1920	interstitial cystitis	Disease	MESH:D018856
37375759	Negative_Correlation	MESH:D047310	MESH:D007249
37375759	Negative_Correlation	MESH:D047310	MESH:D010146
37375759	Association	MESH:D017695	7040
37375759	Positive_Correlation	MESH:D047310	847
37375759	Negative_Correlation	MESH:D047310	7124
37375759	Positive_Correlation	MESH:D003520	MESH:D018856
37375759	Negative_Correlation	MESH:D011453	MESH:D047310
37375759	Negative_Correlation	MESH:D002217	MESH:D047310
37375759	Negative_Correlation	MESH:D047310	MESH:D006470
37375759	Negative_Correlation	MESH:D047310	MESH:D018856
37375759	Negative_Correlation	MESH:D047310	7040
37375759	Negative_Correlation	MESH:D047310	MESH:D004487
37375759	Negative_Correlation	MESH:D047310	MESH:D017695
37375759	Association	MESH:D007249	7124
37375759	Association	MESH:D007249	3569
37375759	Negative_Correlation	MESH:D047310	MESH:D053201
37375759	Positive_Correlation	MESH:D047310	6647
37375759	Negative_Correlation	MESH:D047310	3569

